cemka > Publications > Ophthalmology

Sort publications on year

  • Pharmaco - Epidemiology

    Blindness, low vision, and other handicaps as risk factors attached to institutional residence

    BREZIN A,LAFUMA A, FAGNANI F, MESBAH M, BERDEAUX G

    Br J Ophtalmol ; 88(10):1330-1337

  • Pharmaco-Economics

    Clinical outcomes of glaucoma Treatments Over a patient lifetime : a Markov Model

    NORDMANN JP, LAFUMA A, DESCHASEAUX-VOINET C, BERDEAUX G

    J Glaucoma ; 14(6):463-469

  • Pharmaco-Economics

    Medical predictive Factors of Glaucoma Treatment Costs

    DENIS P, LAFUMA A, BERDEAUX G

    J Glaucoma ; 13(4):283-290

  • Pharmaco-Economics

    Cost and effectiveness of brinzolamide versus dorzolamide in current practice : an analysis based on the UK-GPRD database

    DESCHASEAUX-VOINET C, LAFUMA A, BERDEAUX G

    Journal of Medical Economics ; 6 :69-78

  • Pharmaco-Economics

    Cost-effectiveness of olopatadine in seasonal allergic conjunctivitis treatment

    LAFUMA A, SMITH AF

    Expert Rev Pharmacoecon Outcomes Res ; 2(6): 89-94

  • Pharmaco-Economics

    Cost effectiveness of Emedastine versus Levocabastine in the Treatment of Allergic Conjunctivitis in 7 European Countries

    GOUVEIA PINTO C, LAFUMA A, FAGNANI F, NUIJTEN MJC, BERDEAUX G

    Pharmacoeconomics ; 19 (3): 255-265

  • Biometry and database analysis

    Long-term outcomes and risk factors for failure with the EX-press glaucoma drainage device.

    MARIOTTI C, DAHAN E, NICOLAI M, LEVITZ L, BOUEE S.

    Eye ; 2014;28(1):1-8

  • Biometry and database analysis

    Response to: RE: Long-term outcomes and risk factors for failure with the EX-press glaucoma drainage device.

    MARIOTTI C, DAHAN E, NICOLAI M, LEVITZ L, BOUEE S.

    Eye ; 2014;28(8):1034-1035

  • Pharmaco - Epidemiology

    Prevalence and risk factors for ocular surface disease among patients treated over the long term for glaucoma or ocular hypertension.

    BAUDOUIN C, RENARD JP, NORDMANN JP, DENIS P, LACHKAR Y, SELLEM E, ROULAND JF, JEANBAT V, BOUEE S.

    Eur J Ophtalmol ; 2013;23(1):47-54

  • Biometry and database analysis

    Transforming scales of measurement of visual acuity at the group level

    KHOSHNOOD B, MESBAH M, JEANBAT V, LAFUMA A, BERDEAUX G

    Ophthalmic Physiol Opt ; 2010;30(6):816-823

  • Pharmaco - Epidemiology

    Neodymium : YAG laser rates after bilateral implantation of hydrophobic or hydrophilic multifocal intraoculenses : twenty-four month retrospective comparative study

    GAUTHIER L, LAFUMA A, LAURENDEAU C, BERDEAUX G

    J Cataract Refract Surg ; 2010;36(7):1195-1200

  • Pharmaco - Epidemiology

    Measurement of treatment compliance using a medical device for glaucoma patients associated with intraocular pressure control : a survey

    NORDMANN JP, BAUDOUIN C, RENARD JP, DENIS P, LAFUMA A, LAURENDEAU C, JEANBAT V, BERDEAUX G

    Clin Ophtalmol ; 2010;4:731-739

  • Pharmaco-Economics

    Lifetime costs and effectiveness of ReSTOR compared with a monofocal IOL and Array-SA40 in the Netherlands

    DE VRIES NE, LAURENDEAU C, LAFUMA A, BERDEAUX G, NUIJTS RM

    Eye ; 2010;24(4):663-672

  • Pharmaco-Economics

    Inpatient costs of endophthalmitis evaluated for the whole of France

    COLIN X, BERDEAUX G, LAFUMA A, SALVANET-BOUCHARA A, KODJIKIAN L

    Appl Health Econ Health Policy ; 2010;8(1):53-60

  • Pharmaco-Economics

    Efficacy of moxifloxacin in treating bacterial conjunctivitis : a meta-analysis

    KODJIKIAN L, LAFUMA A, KHOSHNOOD B, LAURENDEAU C, BERDEAUX G

    J Fr Ophtalmol ; 2010;33(4):227-233